Literature DB >> 22478966

Stability of norepinephrine solutions in normal saline and 5% dextrose in water.

Scott E Walker1, Shirley Law, Jill Garland, Esther Fung, John Iazzetta.   

Abstract

BACKGROUND: Most previous stability studies for norepinephrine have reported the percentage of drug remaining in IV solutions after only 24 h. No previously published study has evaluated the effect of light on the stability of this drug.
OBJECTIVE: To evaluate the stability of norepinephrine (64 mg/L) in either normal saline (NS; 0.9% sodium chloride) or 5% dextrose in water (D5W) with storage at either 4°C or room temperature (23°C) in polyvinyl chloride (PVC) bags exposed to or protected from normal room lighting for 2 months.
METHODS: Thirty-two PVC bags were prepared, each containing norepinephrine at 64 mg/L; half of the bags had normal saline as the diluent and the other half had D5W. The bags were stored at either 4°C or room temperature (23°C), with protection from or exposure to ambient fluorescent room light. Overall, there were 4 bags for each combination of diluent, temperature, and light condition. The concentration of norepinephrine in each bag was determined by a validated, stability-indicating liquid chromatographic method on study days 0, 1, 2, 3, 4, 8, 9, 10, 11, 14, 18, 21, 23, 25, 28, 30, 36, 42, and 61.
RESULTS: Analysis of variance revealed differences in percentage remaining as a function of study day (p < 0.001) and light conditions (p < 0.001), but not diluent (p = 0.06) or storage temperature (p > 0.99).
CONCLUSIONS: Solutions of norepinephrine 64 mg/L in NS or D5W can be stored in PVC bags at 4°C for up to 61 days with protection from light. This expiry date allows for up to 24 h storage at 23°C. Solutions that are not protected from light will retain only 90% of the initial concentration after storage for 39 days at 4°C. This storage period could include up to 24 h at room temperature, without protection from light.

Entities:  

Year:  2010        PMID: 22478966      PMCID: PMC2858500          DOI: 10.4212/cjhp.v63i2.896

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  16 in total

1.  Cost effective evaluation of a stability study.

Authors:  S E Walker; Y Hanabusa; G Dranitsaris; W R Bartle; J Iazzetta
Journal:  Can J Hosp Pharm       Date:  1987-08

2.  USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.

Authors:  Eric S Kastango; Brian D Bradshaw
Journal:  Am J Health Syst Pharm       Date:  2004-09-15       Impact factor: 2.637

3.  The stability of noradrenaline in physiological saline solutions.

Authors:  I E Hughes; J A Smith
Journal:  J Pharm Pharmacol       Date:  1978-02       Impact factor: 3.765

4.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

5.  Sample size calculations for clinical pharmacology studies.

Authors:  P D Stolley; B L Strom
Journal:  Clin Pharmacol Ther       Date:  1986-05       Impact factor: 6.875

6.  [Studies of stability for dl-norepinephrine in solutions].

Authors:  H Tokunaga; T Kimura; J Kawamura
Journal:  Eisei Shikenjo Hokoku       Date:  1982

7.  [The effect of visible light on the stability of isoprenaline, epinephrine and levarterenol solutions in various containers. 86. Problems in the use of plastic containers for liquid preparations. 21. The stability of drugs and preparations].

Authors:  H Wollmann; R Grünert
Journal:  Pharmazie       Date:  1984-03       Impact factor: 1.267

8.  The stability of four catecholamines in 5% glucose infusions.

Authors:  M C Allwood
Journal:  J Clin Pharm Ther       Date:  1991-10       Impact factor: 2.512

9.  Stability of five catecholamines and terbutaline sulfate in 5% dextrose injection in the absence and presence of aminophylline.

Authors:  D W Newton; E Y Fung; D A Williams
Journal:  Am J Hosp Pharm       Date:  1981-09

10.  Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.

Authors:  J A Grillo; E R Gonzalez; A Ramaiya; H T Karnes; B Wells
Journal:  Crit Care Med       Date:  1995-06       Impact factor: 7.598

View more
  2 in total

1.  Long-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mL.

Authors:  Sixtine Gilliot; Morgane Masse; Stéphanie Genay; Damien Lannoy; Christine Barthélémy; Bertrand Décaudin; Pascal Odou
Journal:  Eur J Hosp Pharm       Date:  2020-02-06

2.  A Mobile Device App to Reduce Time to Drug Delivery and Medication Errors During Simulated Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial.

Authors:  Johan N Siebert; Frederic Ehrler; Christophe Combescure; Laurence Lacroix; Kevin Haddad; Oliver Sanchez; Alain Gervaix; Christian Lovis; Sergio Manzano
Journal:  J Med Internet Res       Date:  2017-02-01       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.